论文部分内容阅读
近年来支气管哮喘的发病率不断上升 ,虽然建立了哮喘气道慢性炎症病理基础学说 ,哮喘的防治有了突破性进展 ,但其病死率仍有上升趋势 ,尤其是中重度哮喘 ,临床治疗比较棘手。1999年 1月～ 2 0 0 1年 9月 ,我们应用前列腺素Ｅ1(ＰＧＥ1)治疗中重度支气管哮喘 5 8例 ,与同期应用
In recent years, the incidence of bronchial asthma continues to rise, although the establishment of the basic theory of chronic airway inflammation in asthma, prevention and treatment of asthma has made a breakthrough, but its mortality is still on the rise, especially in moderate and severe asthma, clinical treatment more difficult . January 1999 ~ September 2001, we applied prostaglandin E1 (PGE1) treatment of 58 cases of moderate and severe bronchial asthma, with the same period of application